Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder
Condition(s) studied
Investigational drug(s) / intervention(s)
Face-to-face interviews assisted by a biographical grid: Face-to-face interviews assisted by a biographical grid. Healthcare event of the adolescent : * medical specialist appointment * general practitioner appointment * emergency services use * hospital admission * diagnostic test * medication use * non-pharmacological treatment * nursing or physical therapy * alternative care Biographical of the adolescent : * Education event * Class/level * School * Attendance * Special arrangements * Grades * Off school education * Family event * Separation/union * Birth/death * Leave/Arrival * Location/Moving * Disease/accident * Peer events * Friendships * Love interests * Bullying * Leisure \& interests events * Activity * Frequency
Study summary
This study aims to describe the course of successive care events that follow individuals with somatic symptom disorder until they are assessed by a specialized multidisciplinary team. Data is collected during interviews with subjects aged 12 to 25 years old accompanied by their parents. A biographical grid is used to retrospectively identify all care events that occurred from first symptoms until multidisciplinary assessment. Life events and symptoms are collected as well to explore how history of healthcare consumption is linked to other trajectories. A qualitative analysis of the recorded interviews aims to describe the subjective experience of this healthcare pathway.
Eligibility
Primary outcome measure(s)
- Occurrence of healthcare events — Day of inclusion
Successive healthcare events of individuals with somatic symptom disorder, from first symptoms to specialised multidisciplinary assessment
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Maison de Solenn Maison des Adolescents, Cochin Hospital | Paris | IDF | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06582173 on ClinicalTrials.gov ↗ ← All trials in France